Associations of antiplatelet therapy and beta blockade with patient outcomes in atherosclerotic renovascular disease

Journal of the American Society of Hypertension : JASH
James RitchiePhilip A Kalra

Abstract

Randomized trials have shown a neutral effect of percutaneous revascularization compared with optimal medical therapy in patients with atherosclerotic renovascular disease (ARVD). However, there are few data to define what constitutes optimal medical therapy. We present a retrospective analysis of 529 ARVD patients. Separate analyses were performed comparing outcomes in patients prescribed/not prescribed beta blocker and antiplatelet agents. Analyses were adjusted for effects of baseline covariates on probability of treatment and on clinical outcome. Over a median follow-up period of 3.8 years, antiplatelet therapy was associated with a reduced risk for death (relative risk, 0.52 [95% confidence interval {CI}: 0.31-0.89]; P = .02). Beta blocker therapy was associated with a reduced for death (relative risk, 0.45 [95% CI: 0.21-0.97]; P = .04) and nonfatal cardiovascular events (relative risk, 0.74 [95% CI: 0.60-0.90]; P = .003). Although limited by small patient numbers, this study suggests that in ARVD, treatment with antiplatelet therapy and beta blockade may associate with a prognostic benefit.

References

Sep 18, 2004·Circulation Research·Sharon M Moe, Neal X Chen
Jul 29, 2005·Journal of the American Society of Nephrology : JASN·Julian R WrightPhilip A Kalra
Dec 21, 2005·Heart·UNKNOWN British Cardiac SocietyUNKNOWN Stroke Association
Jun 2, 2006·Journal of the American Society of Nephrology : JASN·Marcello TonelliAmit X Garg
Oct 6, 2006·Kidney International·G L BakrisE Ritz
Aug 24, 2007·Nephron. Clinical Practice·Ching M CheungPhilip A Kalra
May 21, 2008·Circulation·Christopher J CooperSadik Khuder
Jun 3, 2008·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Francesca TentoriFriedrich K Port
Sep 2, 2008·American Heart Journal·Daniel G HackamAmit X Garg
Oct 1, 2008·Statistics in Medicine·P R WilliamsonA G Marson
Jan 22, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Marie EvansCarl-Gustaf Elinder
Feb 10, 2009·QJM : Monthly Journal of the Association of Physicians·C ChrysochouP A Kalra
Mar 20, 2009·Journal of the American Society of Nephrology : JASN·Kevin E ChanRaymond M Hakim
Nov 13, 2009·The New England Journal of Medicine·UNKNOWN ASTRAL InvestigatorsJohn Scoble
Nov 18, 2009·Progress in Cardiovascular Diseases·Lilach O LermanJoseph P Grande
Feb 4, 2010·JAMA : the Journal of the American Medical Association·Brenda R HemmelgarnUNKNOWN Alberta Kidney Disease Network
Jun 12, 2010·Vascular Health and Risk Management·Janet B McGill
Dec 16, 2010·European Heart Journal·Daniel G HackamAmit X Garg
Mar 10, 2011·American Journal of Epidemiology·Michele Jonsson FunkMarie Davidian
Jul 2, 2011·Journal of Hypertension·Jorge E ToblliFernando P Dominici
Aug 27, 2011·BMJ : British Medical Journal·Taryn KrauseUNKNOWN Guideline Development Group
Oct 14, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Constantina ChrysochouPhilip A Kalra
Apr 13, 2012·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Carmelita MarcantoniPietro Castellino
Aug 28, 2012·Journal of cardiology·Masatsugu Hori, Hiroshi Okamoto
Sep 4, 2012·European Journal of Internal Medicine·C T PostmaTh Thien
Mar 7, 2013·JAMA : the Journal of the American Medical Association·Peng Foo WongGerard Stansby
Oct 1, 2013·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·James RitchiePhilip A Kalra
Nov 20, 2013·The New England Journal of Medicine·Christopher J CooperUNKNOWN CORAL Investigators
Dec 24, 2013·Advances in Chronic Kidney Disease·Jerry Yee
Mar 4, 2014·Journal of the American Society of Hypertension : JASH·Abdur Rahman KhanSamer J Khouri
Mar 13, 2014·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Richard HaynesUNKNOWN SHARP Collaborative Group
Apr 18, 2014·Journal of Immunology Research·Osamu TakaseRichard J Quigg
Apr 20, 2014·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Paola CaielliGian Paolo Rossi
Nov 18, 2014·Nephron. Clinical Practice·Kosaku NittaKen Tsuchiya
Jun 9, 2015·Journal of the American Society of Hypertension : JASH·David A FoltChristopher J Cooper

❮ Previous
Next ❯

Citations

Jun 26, 2018·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Diana VassalloPhilip A Kalra

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Arrhythmogenic Right Ventricular Dysplasia

Arrhythmogenic right ventricular dysplasia is a congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the right ventricle wall and loss of myocardial cells. Primary injuries usually are at the free wall of the right ventricular and right atria resulting in ventricular and supraventricular arrhythmias. Discover the latest research on arrhythmogenic right ventricular dysplasia here.

Related Papers

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Natalie J IvesRichard Gray
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Attilio LositoLuciano Lupattelli
The New England Journal of Medicine
ASTRAL InvestigatorsJohn Scoble
© 2022 Meta ULC. All rights reserved